Sodium sulphite isn't new to pharmaceuticals or industry. Chemists in the 19th century noticed how its reducing properties tamed oxidation in sensitive solutions. By the 20th century, its use had spread beyond the laboratory bench to industrial scale, steadying everything from photographic developers to food preservation. Pharmaceutical standards grew more detailed over the decades. Both British Pharmacopoeia (BP) and European Pharmacopoeia (EP) refined the expected purity, and the United States Pharmacopeia (USP) set out testing guidelines that check for contaminants, consistency and functional behavior in drug production. Today’s pharma grade sodium sulphite owes its story to decades of science, regulation, and practical demand. The push for tighter batch-to-batch control and transparency meant manufacturers now invest more than ever in traceability, documentation, and validation. No shortcut around it. If you want to sell an excipient for injectable drugs, every step in that supply chain gets scrutinized. Every ounce tracked.
Ask people in industry about sodium sulphite, and they’ll say: “It stops things from going bad.” Truth is, it does a lot more. This white, crystalline powder shows up in injectable and oral formulations where oxidation ruins drug stability. Its main aim is to keep everything fresh through storage, transport and patient use. What lands on the pharma grade label isn’t a wild mixture — it’s tested for heavy metals, water-insoluble material, and microbial cleanliness. Some manufacturers even double down on secondary testing to stand out, tracing any foreign substance down to the smallest part per million. This type of diligence isn’t marketing fluff; regulatory investigators expect it. That intense oversight weaves its way into every drum and every certificate analysts file away.
In solid form, sodium sulphite looks boring: white, powdery, not much smell. Anyone who’s worked in a lab knows its true side comes out in water. It dissolves easily, leaving a mildly alkaline solution that holds up well under cool, dry storage. The reducing power shines when exposed to oxygen; it “grabs” those reactive oxygen atoms, forming sodium sulphate, which is much friendlier for sensitive chemicals or biological molecules. The pH typically hovers above 9, which might throw off acidity-sensitive ingredients. Solubility can top 28 grams per 100 milliliters at room temperature. In my work with bulk batch prep, getting the water temperature right meant fewer clumps and better handling. Impurities like iron or copper must stay almost absent, since they could kill the antioxidant power — or worse, harm health in injected solutions. Particle size matters for fast solution prep or blending, but sharp focus remains on purity and trace defects.
Few details get skipped in an audited facility. Labels on BP, EP or USP pharma grade sodium sulphite spell out batch number, production date, shelf life, and “Pharma Grade” status. A good manufacturer prints out Certificates of Analysis with every order. These papers report assay percentage, water content, pH, insoluble material, and trace heavy metals. I once worked on a production team where one label error led to an entire shipment getting rejected; accuracy and regulatory alignment pay off. Storage instructions sit right on the container, reminding all about moisture control and the need to avoid air exposure. A warehouse tech needs to grab any drum and know, at a glance, if it fits a sterile injectable process or is for non-critical steps like cleaning. Full hazard icons and transport data stand nearby, keeping safety teams and shippers satisfied.
Modern production of pharma-grade sodium sulphite leans on clean sodium carbonate and high-grade sulphur dioxide gas. Manufacturers dissolve the carbonate in pure water, bubble in SO₂, and use careful temperature and pH control to drive the reaction toward high conversion. After reacting, everything gets filtered and dried, sometimes under vacuum to stop reabsorption of water and prevent clumping. Purity gets checked at various stages; folks take pride in reading lab tests showing no hint of iron, arsenic, or insoluble grit. A good plant manager knows that skipping tight reaction control leads to purity failures or caking — and that’s trouble for sterile drug makers. GMP guidelines require recordkeeping for every batch, lot, and shift involved; traceability keeps the risk way down if problems surface. Any new process changes call for revalidation — a long and careful job few want to rush.
Sodium sulphite shines with a range of chemical tricks thanks to its reducing strength. It saps out chlorine and iodine from organic synthesis steps, speeds up diazotization, and helps restore metals in unwanted oxidation states to their friendlier forms. Once in contact with acids, it releases sulphur dioxide gas — useful, but hazardous if workers skip the goggles and proper ventilation. Sodium sulphite salts also play helper roles, conditioning water, stabilizing certain fermentation broths, and stripping off stubborn contaminants during cleaning. Chemists working on new modifications sometimes tweak particle size, hydrate content, or blend it with buffers to fine-tune performance in custom applications. I’ve run into custom requests before; a team of scientists may want it spray-dried or micronized for a niche drug layer or packaging material, pushing suppliers to develop tailor-made grades for high-value work.
Chemical commerce never sticks to one name. In the trade, sodium sulphite pops up as Disodium sulphite, Natrii sulfas, and Sodium sulphite anhydrous. Packaging sometimes lists its CAS No. 7757-83-7. Certain catalogs use the “BP” or “USP” tag to underline who checked and approved the lot. Names do the heavy lifting in procurement, since small shifts in naming mean big changes in grade, purity or intended use. For drug makers, an in-house “pharma grade” label might not satisfy a global auditor unless it matches the published pharmacopoeias. It’s easy to think naming details are a waste of time until an import inspector holds up a valuable shipment for clarification. Consistent and full naming avoids mistakes and upset production schedules.
Sodium sulphite isn’t dangerous at a glance, but mishandling brings chemical burns and lung irritation. Pharma-grade supply chains follow strict safety data sheets, detailed SOPs, and require ongoing training for staff. In working environments, gloves and goggles are non-negotiable, especially since accidental acid contact can release toxic SO₂. OSHA rules and EU REACH guidelines push for clear handling protocols, routine air and surface monitoring, and clear signage across storage and production spaces. Pharmaceutical buyers insist on “food contact appropriateness” if their process crosses into oral or parenteral routes, and push for full audits that walk through the producers’ risk management program. I’ve seen rush orders lose days over missing safety forms or unclear material tracking, and no one enjoys retraining a team after a chemical splash.
In pharmaceuticals, sodium sulphite’s main job is stopping oxidation runs away with active compounds. Injectables and biologics benefit from its reducing power. Large-volume labs rely on it to protect vitamins, flavors, dyes, and biologicals across manufacturing. Diagnostic kit builders place trust in its antioxidant boost to preserve the shelf stability of test reagents. Beyond pharma, it extends shelf life in dried fruits, slows yellowing in textiles, and keeps pulp and paper processes on track. Certain laboratories use it as a mild, clean backup to harsher chemicals, especially in processes connected to patient therapies or in-process sample preparations. Many industrial users draw a hard line between pharma and technical grades — only the former passes the scrutiny needed for injectable drugs or anything involving patient exposure.
R&D groups in pharmaceuticals see sodium sulphite as more than a basic antioxidant. Formulation chemists experiment with low-dose, high-purity sodium sulphite in biologic mixtures, reducing oxidation without compromising activity or safety. Scientists focus on secondary interactions: how traces of the salt interact with metal-based excipients or set off side reactions with peptides or proteins. Analytical advances now allow researchers to follow sodium sulphite all the way through a product’s shelf life, parsing out every byproduct or impurity formed. Some R&D teams push for sodium sulphite analogs or derivatives that cut down on undesirable breakdown while improving stability in solution. Global regulators show interest in new excipient science — if a new grade demonstrates improved performance or safer profiles, they may open up alternative routes for drug developers.
Toxicity sits at the heart of every pharmaceutical ingredient assessment. Sodium sulphite toxicity has received careful review in both animal and human data. Orally, large doses can irritate the digestive tract, and inhalation of dust or fumes — especially sulphur dioxide — damages the lungs. Not every patient tolerates sulphites well; those with sulphite sensitivity or asthma can see adverse reactions, including breathing problems or, in severe cases, life-threatening attacks. Regulatory authorities strictly limit allowable daily intake, audit key food and injectable products, and demand presence warnings for patient safety. Ongoing scientific trials push the boundaries, watching low-dose impact, accumulation risk, and special populations like pediatrics or geriatrics. A single uncontrolled batch or labeling error translates immediately to product recalls or regulatory action. My own quality assurance contacts still talk about the sleepless nights during batch investigations when single patient reactions called an entire plant’s output into question.
Application fields continue to expand as both pharmaceutical and biotechnology groups select more advanced excipients. Although established antioxidants like sodium sulphite hold ground, demand for “clean label” excipients drives innovation into higher purity versions and new salt forms. Biotech research leverages its chemistry to stabilize high-value proteins and new vaccine types. Some suppliers invest in “green” manufacturing processes, reducing waste and cutting harsh reagents, responding to pressure from both industry watchdogs and large contract drug manufacturers. Analytical tools grow more advanced, with mass spectrometry mapping every chemical byproduct across a product’s full shelf life, helping ensure a safer, tighter supply chain. Demand won’t disappear. Disease treatment drives global expansion of drug manufacturing, which in turn tests every part of the auxiliary chemicals supply chain. Professionals on the ground know that excipient quality cuts both ways: too pure, and costs climb; too messy, and risk climbs higher. Those with a hand in medicine manufacturing treat sodium sulphite as more than a box tick. It’s a line of defense in an industry where the smallest failure carries the highest stakes.
Walking through any modern pharmaceutical facility, you notice shelves of chemicals, each serving a unique purpose. Sodium sulphite BP EP USP pharma grade might not grab attention at first glance, but it plays an outsized role in some of the most sensitive parts of drug development and formulation.
In my experience working with chemists and pharmacists, preservation always pops up as a challenge. Drugs, especially those with delicate active ingredients, often break down when exposed to air. Sodium sulphite acts as a reducing agent—essentially serving as the quiet guardian that keeps oxygen from spoiling key ingredients. Pharmaceutical labs use this compound in both liquid and solid formulations. Its antioxidant properties help extend the shelf life of drugs and ensure that every tablet and injection delivers the intended effect.
Historical recalls and product failures often point to poor control over oxidation. Using sodium sulphite in production can reduce these risks, helping companies maintain compliance with global safety and quality standards. Less wasted product also means more predictable costs—a practical benefit that everyone in the supply chain notices.
In the pharmaceutical world, purity goes hand-in-hand with safety. BP, EP, and USP grades demand thorough testing for impurities like heavy metals. This isn’t just a technicality. Impure chemicals can trigger side effects and lead to dangerous byproducts. Hospital pharmacists sometimes share stories about adverse reactions traced to off-spec raw materials. Sodium sulphite pharma grade adheres to strict international standards, reducing that risk and building trust with healthcare providers.
Some drugs just don’t play well with water or air. I’ve seen injectable solutions that turn cloudy overnight if left unprotected. Sodium sulphite stabilizes these sensitive formulas. It’s often included in preparations for antibiotics, vitamin solutions (like Vitamin C), and eye drops. These products can break down quickly in the presence of oxygen. By scavenging oxygen, sodium sulphite keeps these solutions clear and potent for much longer, which is critical for life-saving therapies where precision counts.
No chemical comes without responsibility. Allergic reactions and sensitivity to sulphites, though rare, show up, especially among patients with severe asthma. That’s why regulatory agencies set clear labeling requirements. It’s up to manufacturers and pharmacists to monitor doses carefully and communicate risks to patients. The solution isn’t eliminating sodium sulphite—its benefits in protecting drug quality outweigh the risks—but ensuring everyone along the supply chain stays informed.
Pharma companies have looked at alternatives, but sodium sulphite remains popular because of its reliability and affordability. Expanded staff training, meticulous quality checks, and up-to-date labeling on every batch of medication ensure its safe use.
Sodium sulphite BP EP USP pharma grade quietly supports some of the medical world’s most critical products. From my time in the industry, I’ve learned that the best results come when quality, transparency, and patient safety drive day-to-day decisions. Chemicals like sodium sulphite may not make headlines, but their proper use underpins trust in every prescription drug on the shelf.
Every pharmaceutical ingredient makes its way into products people trust with their health. Sodium sulphite isn’t just a chemical name on a label; it supports the stability and safety of medicines. You won’t find shortcuts in this category — customers, manufacturers, and regulators expect consistency and reliability from each batch. Purity isn’t measured just to check a box. It often draws the line between a safe ingredient and something unfit for the pharmacy shelf.
In terms of specifications, sodium sulphite pharma grade usually contains sodium sulphite (Na2SO3) as its lead ingredient at 98-99% minimum purity. That figure signals little room for error because contaminants like heavy metals or insoluble matter have no place in an active pharmaceutical ingredient (API). The United States Pharmacopeia (USP) and the European Pharmacopoeia (Ph. Eur.) typically call for tight limits on substances like iron, arsenic, chloride, and sulfate.
Heavy metals stick out during quality checks — copper, lead, zinc, and mercury must drop below trace amounts, often measured in parts per million or even less. Water content stays low, too, usually below 2%. Moisture lets sodium sulphite degrade; drier material sticks around in a medicine cabinet longer and performs better where it matters.
Uncontrolled impurities can lead to real-world problems. Even something as simple as a trace metal may cause unexpected reactions inside a tablet or vial. A patient, especially one with particular sensitivities, counts on every dose being nearly identical every single time. Pharmaceutical sodium sulphite needs to show a clear “loss on drying” value, confirming it won’t clump or throw off a formulation’s intended effect.
From my own time helping out at a compounding pharmacy, we always looked for the chemical’s certificate of analysis before restocking. Numbers on that paper — total purity, pH range (usually 9-10.5 in solution), and absence of reducing or oxidizing impurities — made a difference. Without that confidence, pharmacists lose sleep and companies run into recalls.
Everything in pharmacy comes down to the confidence of good testing. Labs run titration or spectrophotometric methods to check sodium content. Visual checks for color and foreign matter still happen, since an off-color means the process failed somewhere on the supply chain. Reliable partners run batch numbers traceable straight back to the original production line. Audits don’t just target paperwork — regulators walk the factory, inspect packaging, and demand accountability for every gram shipped.
Raising standards pays off for everyone. Suppliers who pursue international accreditations – ISO 9001, GMP, or equivalent – set the bar for quality. Investing in dedicated storage areas, moisture-proof packaging, and cleaner transportation makes a tangible difference. Sometimes price points push companies to cut corners, but that never ends well in pharma. Transparency and cooperation with regulatory bodies — not just sporadic audits but real partnerships — can step up the quality game.
Sodium sulphite sounds simple, but strict attention to its chemical makeup keeps supply chains honest and protects patients on the receiving end. Documentation, constant verification, and responsible sourcing are more than checkboxes — they define whether a chemical can earn its place inside a medicine bottle.
Walking into any pharmaceutical plant, you can find shelves labeled with chemicals like sodium sulphite. But chemical purity isn’t a detail to overlook. Pharmacopeia standards—British (BP), European (EP), and United States (USP)—aren’t just bureaucratic hoops. They shape safety and reliability for everyone, from labs to hospital patients. These publications list how pure pharmaceutical ingredients must be, right down to the parts per million.
Experience in a quality control lab taught me that even a small amount of impurity can throw off entire production runs. In one case, a batch of sodium sulphite that missed the iron content limit led to weeks of delayed manufacturing. Unchecked iron triggers unwanted reactions in injectable formulas. One small detail causes ripple effects, wasting thousands of dollars and, worse, risking patient health.
Every compendium sets specifications for contaminants—heavy metals, water content, pH, and more. Pharmacopoeias bake in these requirements to prevent issues such as microbial growth in injectable or ophthalmic solutions, which depend on the preservative qualities of sodium sulphite. Without that guarantee of precision, you can’t trust stability data, and shelf life becomes a guessing game.
Responsible procurement teams don’t just accept a supplier’s word. True due diligence happens when a current Certificate of Analysis lines up with every line item in the pharmacopeia’s monograph. Lab testing—done in-house or by a third party—validates these numbers. Establishing that the sodium sulphite batch matches BP, EP, and USP requirements isn’t just for regulatory inspections; it’s the baseline for responsible production.
You can’t get complacent, either. Regulatory bodies like the FDA or EMA perform surprise audits. Companies with tight documentation and reliable purchasing habits weather those inspections with less anxiety and far fewer delays. Failures in compliance translate directly into recalls and reputational damage. The pharma world doesn’t offer much room for second chances.
One way to reduce risk starts before sourcing even begins: vet suppliers through site visits and regular GMP audits. Trust builds with suppliers who don’t hesitate to share up-to-date documentation and quickly address any question about raw material testing. QC departments stay efficient by setting up periodic audits of both paperwork and physical inventory. It’s easier to spot trends and catch possible drifts from the pharmacopeia limits.
Labs that invest in modern analytical tools—ICP-MS for metals detection, Karl Fischer titration for moisture, and FTIR for identity—rarely find themselves playing catch-up. Training staff regularly keeps new hires as sharp as those with decades under their belt. In my view, companies succeed when documentation of every test and shipment is transparent and easy to track without a scavenger hunt across filing cabinets.
Pharmaceutical-grade chemicals support real people—those who depend on cleaner, safer drugs. Pharmacopeia compliance, while detailed and sometimes tedious, acts as a safeguard woven into every step from warehouse to hospital. Whenever any one ingredient slips outside those lines, the stakes hit home.
Pharma companies thrive on transparency, thorough record-keeping, and regular communication with their suppliers and quality teams. Staying ready for regulatory review doesn’t have to be stressful with the right habits in place. Reviewing every test result, every shipment, every supplier visit—these everyday actions fend off bigger headaches down the line.
Most folks working in labs, warehouses, or production lines know that handling chemicals comes with real responsibility. Sodium sulphite stands out as a key ingredient for many pharmaceutical processes, especially in water treatment and as a preservative. Even though this salt may look harmless at first, the risks connected to improper storage or careless handling can catch anyone off-guard.
Old habits, like stacking bags of sodium sulphite wherever space exists or grabbing handfuls without proper protection, get some workers into trouble. Exposing sodium sulphite to open air invites moisture to creep in. This breaks down the product and triggers sulfur dioxide release, irritating the lungs and eyes. Production batches then go to waste, forcing companies to take losses. That sort of trouble isn't just bad luck; it’s preventable.
Dryness always comes up in chemical storage... for good reason. Just one leaky bag or a badly fitted lid can pull in humidity, which reacts with sodium sulphite almost instantly. It turns clumpy, cakes up, or even generates gas inside the package. In my own experience, I once walked into a storage room where humidity had caused an entire stack of product to clump together. We salvaged nothing. Each loss like that leaves an impression. Reliable storage uses moisture-proof containers — think tight poly drums or double-layered bags — and a spot away from any sources of water or damp air. Demand is rising for smarter warehouses monitored with humidity sensors to catch problems before they start. Setting the ideal storage temperature between 15°C and 30°C makes a difference, cutting down the risk of condensation or material breakdown.
All steps in the handling process call for good ventilation. Sodium sulphite reacts with acids and even with traces of certain metals, giving off sulfur dioxide. Workers bumping into unmarked containers may accidentally mix incompatible materials, risking injury or property damage. I asked a warehouse operator once how they managed risk. Their space had clear storage zones, strict labeling, and a team trained to keep acids on the opposite side.
Sometimes, a batch arrives with damaged packaging, or a seal wears out. Staff get tempted to fix problems quickly on the spot. Instead, placing any suspicious container in a segregated area and calling the quality safety team helps prevent accidents. Routine inspections catch early signs of leaks or damaged packaging. The cost of an extra walk-through far outweighs the fallout from a chemical incident.
The core reason most chemical accidents keep happening traces back to people ignoring procedures. Protective gear — nitrile gloves, goggles, and dust masks — seems over-the-top, until someone experiences a stinging nose or red eyes from a careless scoop. Real safety culture forms when everyone sees the point, and supervisors back up training with reminders and quick spot checks. Posters reminding staff about proper protective wear or how to identify product hazards drive the message home without slowing down operations.
No matter how careful anyone is, spills happen. Cleaning up sodium sulphite requires dry methods only. Even a little bit of water can make things worse by setting off a gas release. In my previous role, I watched a less experienced worker reach for a wet mop during a spill — the supervisor stopped them just in time. Instead, brooms, dry cloths, and immediate disposal into labeled chemical waste bins keeps surfaces clear and everyone safe.
Every facility deals with tight budgets. But taking shortcuts on storage and handling winds up costing more in lost product, down time, or even fines. Across all these steps, respect for chemicals like sodium sulphite goes hand-in-hand with keeping businesses running and everyone heading home healthy at the end of the day.
Sodium sulphite grabs a spot in pharmaceutical manufacturing because it keeps things stable and pure. The way this ingredient gets packaged isn’t something anyone can treat as an afterthought. Every step in the supply chain, from the factory floor to hospital storage, depends on packaging that blocks moisture, contamination, and accidental exposure. Quality packaging builds trust and safety into the handling of this chemical.
Over time, I’ve learned to look at safety first, especially while working with powders that react to the air or light. Sodium sulphite’s tendency to pick up water from the air means a basic cardboard box simply doesn’t make the cut. Heavy-duty drums, lined paper bags, and high-barrier plastic or laminated sacks stand out for a reason.
For larger volume needs, manufacturers turn to fiber drums lined with poly bags. These drums keep the powder away from sweating warehouse walls and sudden temperature shifts. A tight lid with a tamper-evident seal reassures everyone down the line that nobody has fiddled with the contents. In factories or large compounding pharmacies, 25 kg drums feel almost standard. Factories that process on an even bigger scale opt for 50 kg drums and super sacks, but these only work if the facility can safely manage that kind of weight and material exposure.
Hospitals, test labs, and small-batch drug makers need much less. For them, the go-to option is the 1 or 5 kg HDPE container. This kind of sturdy, opaque plastic rejects the damp, sunlight, and accidental bumps. I remember seeing these on shelves in cleanrooms, the wide-mouth design making life easier during weighing. Some brands use inner aluminum foil liners under the cap, adding an extra barrier without asking the end-user to fight with hard plastic.
Moving sodium sulphite across borders brings safety headaches. High-quality packaging needs to pass regulatory scrutiny. Most shippers opt for UN-certified drums or cartons, each marked and documented, satisfying both local rules and international ones. In my own experience helping to arrange shipments, customs looked for those familiar black-on-white labels and documentation as much as they cared for the drum or sack itself.
Triple-layer bags (polyethylene, lined paper, and an outer woven sack) give an extra sense of security where humidity runs high. These layered bags allow for safe stacking and help prevent leaks even if something inside sweats a little. Pharmacies storing sodium sulphite on-site keep their containers sealed, often in climate-controlled rooms, proof that packaging really does protect the ingredients pharmacies rely on.
I remember once seeing a batch of sodium sulphite stored in old-style tins, now rusted through and leaking powder. Waste and environmental risk show up fast if packaging isn’t up to the job. Today’s pharmaceutical customers look for recyclable drum liners, re-sealable bags, and materials listed on proper datasheets. The push for eco-friendly packaging means more companies are phasing out PVC and fossil-heavy plastics, picking sturdier films or bioplastics for new drum linings.
My take: safety and compliance win every packaging debate. Transparent supply chains, real traceability, and responsive packaging design help prevent cross-contamination and material loss. Forward-thinking companies now track packaging batches to their source, making recalls less disruptive if something goes wrong. The demand for pre-sterilized packaging, tamper-proof seals, and detailed lot history is driving change, not just for sodium sulphite but for every ingredient in pharma’s arsenal.
Names | |
Preferred IUPAC name | Sodium sulfite |
Other names |
Sodium sulfite Disodium sulfite Sulfurous acid disodium salt Sodium sulphite anhydrous E221 |
Pronunciation | /ˈsəʊdiəm ˈsʌl.faɪt biː piː iː piː juː ɛs piː ˈfɑːrmə ɡreɪd/ |
Identifiers | |
CAS Number | 7757-83-7 |
Beilstein Reference | 3566816 |
ChEBI | CHEBI:37139 |
ChEMBL | CHEMBL string: **CHEMBL1356** |
ChemSpider | 21512 |
DrugBank | DB09466 |
ECHA InfoCard | 19d4b1c5-79b9-41c7-928d-8fde652e6fd2 |
EC Number | 231-821-4 |
Gmelin Reference | 13120 |
KEGG | C01685 |
MeSH | D009670 |
PubChem CID | '24437' |
RTECS number | WV0450000 |
UNII | SY7Q814VPU |
UN number | UN 1847 |
CompTox Dashboard (EPA) | CompTox Dashboard (EPA) of product 'Sodium Sulphite BP EP USP Pharma Grade' is: **DTXSID5078148** |
Properties | |
Chemical formula | Na2SO3 |
Molar mass | 126.04 g/mol |
Appearance | White, free-flowing crystalline powder |
Odor | Odorless |
Density | Density: 2.633 g/cm³ |
Solubility in water | Soluble in water |
log P | -4.1 |
Acidity (pKa) | 7–9 |
Basicity (pKb) | 8.63 |
Magnetic susceptibility (χ) | -9.6 × 10⁻⁶ |
Viscosity | 1.2 (at 20°C, as 10% solution) |
Dipole moment | 5.96 D |
Thermochemistry | |
Std molar entropy (S⦵298) | 126.2 J·mol⁻¹·K⁻¹ |
Std enthalpy of formation (ΔfH⦵298) | -1387 kJ/mol |
Std enthalpy of combustion (ΔcH⦵298) | -1387 kJ/mol |
Pharmacology | |
ATC code | Sodium Sulphite" does not have an ATC code. |
Hazards | |
Main hazards | Harmful if swallowed. Causes serious eye irritation. May cause respiratory irritation. |
GHS labelling | GHS07, GHS09 |
Pictograms | GHS07, GHS09 |
Signal word | Warning |
Hazard statements | H319: Causes serious eye irritation. |
Precautionary statements | P264, P270, P273, P301+P312, P330, P501 |
NFPA 704 (fire diamond) | 2-1-0 |
Autoignition temperature | > 478°C |
Lethal dose or concentration | LD50 (Oral, Rat): 3,560 mg/kg |
LD50 (median dose) | LD50 (oral, rat): 3560 mg/kg |
NIOSH | UNLISTED |
PEL (Permissible) | PEL (Permissible Exposure Limit) for Sodium Sulphite: 5 mg/m³ (as respirable fraction, OSHA TWA) |
REL (Recommended) | 500 ppm |
IDLH (Immediate danger) | Not established |
Related compounds | |
Related compounds |
Sodium bisulfite Sodium metabisulfite Potassium sulfite Sodium thiosulfate Sodium sulfate |